Products

Flatiron Health OncologyCloud
Flatiron Health
Clinical Decision Support & Reference
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer.

See all 1 product →

About Flatiron Health

Flatiron Health is a healthcare technology and services company dedicated to accelerating cancer research and improving patient care. They aim to achieve this by learning from the experience of every person with cancer, combining AI-powered technology, deep clinical expertise, and real-world oncology data. Their global oncology engine is built on one of the world’s largest oncology datasets, spanning the US, UK, Germany, and Japan, and utilizes point-of-care technology in community oncology practices across the US.

Flatiron Health’s platform integrates disparate data systems within cancer centers to provide a comprehensive, longitudinal view of patient populations. This enables administrators and clinicians to gain deep analytics for business and clinical intelligence, resource utilization, treatment patterns, network management, and research. They partner with thousands of providers and life science organizations to generate deeper insights, move faster, and improve outcomes for people living with cancer. Insights from their real-world data have contributed to expanding treatment alternatives for various cancers and understanding the impact of healthcare policy on disparities in treatment access.

Focus Areas

Oncology Real-World Evidence AI/Machine Learning Electronic Health Records (EHR) for Oncology Clinical Research Data Curation and Analytics Personalized Medicine Health Equity

Business Intelligence

TechnologyCloud-based oncology software platform, OncoEMR® (oncology-specific EHR), OncoAnalytics®, Flatiron Clinical Pipe™ (EHR-to-EDC connector), AI and machine learning capabilities for data curation and patient identification, Large Language Models (LLMs)

What Physicians Need to Know

Oncology-Specific EHR (OncoEMR®)
Flatiron Health offers OncoEMR®, a cloud-based electronic health record designed specifically for medical oncology practices. It streamlines patient intake, chemotherapy ordering and dosage management, documentation, and billing preparation. OncoEMR® incorporates oncology-tailored capabilities such as capturing patient-reported outcomes at the point of care and structured treatment documentation.
Real-World Evidence (RWE) & Data Curation
Flatiron Health is a leader in generating high-fidelity, global real-world evidence by combining extensive real-world data, deep oncology expertise, and AI-powered intelligence. They have built one of the world's most comprehensive oncology datasets, encompassing over 5 million patient records and 1.5 billion data points, which continues to grow. Their approach includes a hybrid curation method that combines manual abstraction by clinical experts with automated extraction by machine learning models to ensure data quality and scale. Flatiron's RWE has been used in over 2,000 peer-reviewed publications and has informed over 45 global regulatory decisions.
AI/Machine Learning & Advanced Analytics
Flatiron leverages AI and machine learning, including large language models (LLMs), to extract clinically meaningful information from unstructured EHR data at scale, making de-identified patient data more accessible and actionable. This enables them to move beyond descriptive analytics to uncover the 'why' behind clinical decisions and predict patient outcomes. Their AI models are developed and validated by in-house oncologists and scientists to ensure insights meet the bar for publication, regulatory submission, and commercial decisions.
Clinical Research & Trial Optimization
Flatiron Health's technology and data are used to accelerate clinical research and improve trial efficiency. They offer solutions for patient screening, automated data transfer, and streamlined trial management, helping to identify suitable candidates for clinical trials and broaden access to pioneering treatments. Their platforms can help identify the right patient cohorts for various cancer conditions for clinical trials.
Personalized Medicine
Flatiron Health aims to make personalized medicine a reality in oncology by leveraging vast amounts of patient data and machine learning to optimize treatment regimens for individual cancer patients, minimizing adverse events. They provide actionable genomic insights and precision medicine tools at the point of care.
Health Equity
Flatiron Health is committed to addressing health equity and disparities in cancer care. They conduct research to identify gaps in care delivery and improve outcomes for underserved patient cohorts. Their collaborations aim to enhance the delivery of evidence-based care, boost health equity, and improve patient experiences.
Physician Tip

Flatiron Health's offerings, particularly OncoEMR® and Flatiron Assist™, are designed to integrate seamlessly into oncology workflows, providing intuitive, AI-powered tools that reduce administrative burden and support evidence-based decision-making at the point of care. Physicians can benefit from automated reporting for value-based care programs, embedded evidence-based regimens and pathways, and tools to create comprehensive care plans. Flatiron Assist™ provides up-to-date NCCN Guidelines®, site-specific treatment pathways, and relevant clinical trial information directly within the EHR, leading to improved adherence to guidelines and a reduction in unique treatment regimens. The platform also helps streamline prior authorizations and capture data that drives revenue. The company's focus on high-quality, curated real-world data, combined with AI, helps surface critical patient details that can inform treatment decisions and connect patients with appropriate clinical trials more efficiently.

Flatiron Health's OncoEMR® integrates with various technology and service providers through its Trusted Partner Network, aiming to optimize oncology workflows and improve patient outcomes. Recent partnerships include those with DeepScribe for oncology-specific ambient AI, Candid Health for revenue cycle management, TailorMed for medication access, and Quest Diagnostics for expanded oncology test access. Flatiron also offers Flatiron Clinical Pipe, an EHR-to-EDC connector that simplifies data management for clinical studies by seamlessly transferring relevant study data, reducing manual data entry and improving data accuracy. Their clinical decision support platform, Flatiron Assist™, is seamlessly integrated into EHRs.

Products by Flatiron Health

1 product in the directory

Flatiron Health OncologyCloud
Flatiron Health
Clinical Decision Support & Reference
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer.

What the Web Says

Flatiron Health is a health technology company focused on improving cancer care through data and technology. The company generally receives positive reviews for its mission-driven culture, supportive environment, and strong work-life balance. However, some product reviews indicate areas for improvement in reporting functionality and data access.

Overall: Mixed

Strengths

  • Mission-driven work in oncology with a clear connection to patient impact.
  • Supportive and kind colleagues and management.
  • Good work-life balance and flexibility, including remote work options.
  • Opportunities for professional development and growth.
  • Competitive compensation, benefits, and financial resources.
  • User-friendly and easy-to-learn OncoEMR product with engaged onboarding support.

Limitations

  • Product limitations in reporting functionality and access to data fields.
  • Some users find the company disorganized and unprofessional.
  • Potential for low pay and lack of increases for some roles, with occasional work shortages for part-time positions.
  • Leadership could improve communication and transparency regarding business trajectory.
  • Junior employees may experience limited growth opportunities.
  • Recent changes to task feedback have made performance evaluations difficult to understand for some roles.

Based on reviews from: Built In, Indeed, Comparably, Handshake, Elion Health, Capterra, Reddit

Last updated: 2026-10-23

Videos

News, demos, and interviews about Flatiron Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Flatiron Health →

View all on YouTube

Press & Coverage

Flatiron Health
Flatiron Health Announces Research at ESMO Congress 2026 Examining Cancer Treatment and Outcomes Across Global Markets
Flatiron Health announced that four research abstracts will be presented at the ESMO Congress 2026, focusing on cancer treatment and outcomes in the US, Germany, Japan, and the UK. The research examines treatment patterns, patient outcomes, and areas where more evidence could improve care.
2026-10
Business Wire
Flatiron Health Expands Telescope to International Real-World Data, Bringing AI-Powered Oncology Insights to a Global Database of More Than Six Million Patients
Flatiron Health has expanded its AI-powered oncology intelligence platform, Flatiron Telescope, to include datasets from the UK, Germany, and Japan. This expansion allows life sciences teams to ask and answer oncology questions using a global real-world database of over six million patients.
2026-10
BioSpace
Flatiron Health's Breast Cancer Panoramic Dataset Surpasses One Million Patients, Enabling Real-World Research at Unprecedented Scale
Flatiron Health announced that its Breast Cancer Panoramic dataset has exceeded one million patients, making it the largest rigorously curated breast cancer real-world dataset of its kind. This milestone supports precision medicine research across the full breast cancer continuum.
2026-10
Flatiron Health
NCCN and Flatiron Health Announce Renewal of Collaboration to Advance Real-World Data Research Across Leading Cancer Centers
Flatiron Health and the National Comprehensive Cancer Network (NCCN) have renewed their collaboration, extending through 2028. This partnership aims to advance real-world evidence research across NCCN academic medical centers and introduces Flatiron Telescope for broader research opportunities.
2026-09
Flatiron Health
Flatiron Health publishes first peer-reviewed validation framework for AI-extracted real-world oncology data in Journal of Clinical Oncology
Flatiron Health published the Validation of Accuracy for LLM/ML-Extracted Information and Data (VALID) Framework in the Journal of Clinical Oncology Clinical Cancer Informatics. This framework is the first peer-reviewed approach to evaluating the quality of real-world data extracted by large language models and machine learning.
2026-04
Business Wire
Flatiron Health Launches Flatiron Telescope, a New AI Platform Delivering Oncology Insights in Minutes
Flatiron Health launched Flatiron Telescope, an AI-powered platform designed to help life sciences teams and researchers quickly find patients, assess study feasibility, and generate oncology insights on demand. The platform translates complex criteria into actionable patient cohorts using natural language.
2026-05
Signalbase
Flatiron Health Raises $175 Million Series C Funding
Flatiron Health secured $175 million in Series C funding, demonstrating strong investor confidence in its approach to leveraging real-world data and technology to accelerate cancer research and enhance patient care.
2026-03
Healthcare IT News
Flatiron, National Cancer Institute announce partnership and more digital health news
Flatiron Health is collaborating with NRG Oncology, a National Cancer Institute clinical research consortium, to deploy Flatiron Clinical Pipe in a multicenter clinical trial. This aims to improve efficiency and reduce the effort of clinical study data entry.
2025-03

Frequently Asked Questions

Flatiron Health leverages its extensive network of oncology EHRs to generate real-world evidence, providing insights into treatment patterns, patient outcomes, and drug effectiveness outside of traditional clinical trials. This RWE supports research into personalized medicine by identifying patient subgroups that may benefit most from specific therapies. The data sources primarily include de-identified patient data from community oncology practices and academic centers, meticulously curated for research-grade quality.
Flatiron Health utilizes AI and Machine Learning to enhance the quality and utility of its oncology data. This includes automating aspects of data curation, improving the accuracy of clinical trial matching for patients, and identifying potential health equity disparities by analyzing treatment access and outcomes across different demographic groups. These technologies help to unlock deeper insights from complex oncology data.
Flatiron Health's OncoEMR® is an oncology-specific electronic health record system designed to streamline clinical workflows and improve patient care. It offers features tailored to oncology, such as chemotherapy ordering, treatment planning, and outcomes tracking. Flatiron Health provides comprehensive support for implementation, including data migration and staff training, as well as ongoing technical support and regular updates to ensure seamless integration and optimal use within existing hospital systems.
Flatiron Health adheres to stringent compliance standards for patient data privacy and security, including HIPAA and GDPR regulations. All patient data is de-identified and aggregated before being used for research purposes or shared with partners. Robust security measures, including encryption and access controls, are in place to protect sensitive information, ensuring patient confidentiality and data integrity throughout collaborations with pharmaceutical partners for clinical research.
Flatiron Health collaborates with pharmaceutical companies and academic institutions to accelerate oncology research and drug development. These partnerships involve sharing de-identified real-world data to inform clinical trial design, identify new therapeutic targets, and evaluate the effectiveness of approved treatments in diverse patient populations. These collaborations ultimately aim to bring new and more effective cancer therapies to patients faster.
Flatiron Health's pricing model for its EHR and data analytics products is typically tailored to the specific needs and size of the oncology practice or healthcare system. While specific pricing details are not publicly disclosed, options are generally available to accommodate various organizational scales, from smaller community practices to larger academic centers. Interested parties are encouraged to contact Flatiron Health directly for a customized quote and to discuss available solutions.
Flatiron Health is committed to addressing health equity concerns in oncology by analyzing real-world data to identify disparities in cancer care access, treatment patterns, and outcomes across different populations. While specific products are not detailed, their data analytics capabilities can highlight underserved communities and inform initiatives aimed at reducing these disparities. By providing insights into real-world patient journeys, Flatiron Health helps stakeholders develop targeted interventions to promote more equitable cancer care.

Investors

Who's funded Flatiron Health.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.